FURIN rs17514846: Blood Pressure and Longevity Genetics
rs17514846 is an intronic single nucleotide polymorphism located in the FURIN gene on chromosome 15. Research links this variant to regulatory changes in gene expression that influence blood pressure regulation and coronary artery disease risk. Large-scale genome-wide association studies have also identified rs17514846 as a marker significantly associated with parental survival and human longevity.
What each genotype means
Higher FURIN expression
Research indicates that the A allele is associated with higher levels of FURIN expression in vascular endothelial cells and heart tissue. While this variant has been linked to longevity and blood pressure regulation in some studies, it is also investigated as a potential risk factor for coronary artery disease. These associations are complex and may vary by population, so this information should not be used to predict individual health outcomes.
This genotype is common, with the minor allele frequency for this variant typically ranging between 0.35 and 0.45 across European and East Asian cohorts.
Intermediate FURIN expression
Carrying one copy of each allele results in an intermediate profile regarding the regulatory effects on FURIN expression observed in research. Because this variant is located in an intronic regulatory region, its influence on healthspan and longevity is considered a subject of ongoing study rather than a definitive clinical marker. Please consult with a healthcare professional if you have concerns about cardiovascular health or blood pressure.
This heterozygous genotype is frequently observed in populations where the minor allele frequency for this variant is approximately 0.35 to 0.45.
Lower FURIN expression
The C allele is associated with lower levels of FURIN expression in vascular tissues compared to the A allele. While some research links this genetic region to longevity and parental survival, the evidence remains limited and associations with disease risk are not absolute. This genotype represents a common variation in the human genome and should be interpreted as part of a broader polygenic context.
This genotype is common, occurring in a significant portion of the population consistent with the reported minor allele frequency of 0.35 to 0.45 for this variant.
Genetic Location and Variant Details
The single nucleotide polymorphism rs17514846 is situated on chromosome 15q26.1 within an intronic region of the FURIN gene. Because it is located in a non-coding portion of the gene, rs17514846 does not directly alter the amino acid sequence of the encoded protein. Instead, functional genomic evaluations suggest that the variant resides within a critical transcriptional regulatory region. Bioinformatic and molecular analyses indicate that variations at this locus can act as expression quantitative trait loci (eQTLs), influencing the transcription levels of FURIN as well as adjacent genes in the 15q26.1 cluster. While rs17514846 is frequently highlighted in genetic association studies, researchers note that strong linkage disequilibrium across this chromosomal region means other nearby variants may also contribute to observed regulatory differences.
The Biological Role of the FURIN Gene
The FURIN gene encodes a calcium-dependent proprotein convertase enzyme known as furin, which plays an essential role in processing precursor proteins into their biologically active states. Furin cleaves target substrates within the trans-Golgi network and secretory pathway, regulating diverse processes such as lipid metabolism, inflammatory signaling, and vascular remodeling. Crucially, furin is heavily involved in the renin-angiotensin-aldosterone system and sodium-electrolyte homeostasis, both of which are central to systemic blood pressure maintenance. Alterations in FURIN expression or enzymatic activity have been implicated in cardiovascular remodeling, atherosclerotic plaque development, and lipid handling, making the gene a focal point for cardiovascular physiology and metabolic health research.
Scientific Research on Longevity and Cardiovascular Traits
Genetic association studies have repeatedly implicated rs17514846 in cardiovascular outcomes and lifespan. Large-scale genome-wide association studies investigating parental survival and attained lifespan, including extensive cohorts like the UK Biobank, identified rs17514846 as a significant longevity-associated locus. Prior to these longevity findings, the variant was primarily characterized through its statistical links to blood pressure variation, triglyceride levels, metabolic syndrome, and coronary artery disease risk. Autopsy studies and functional assays have revealed that the A allele correlates with differential FURIN expression in cardiac tissue and early-stage coronary atherosclerosis. However, evidence remains categorized as limited to moderate because the absolute statistical effect sizes on individual lifespan and blood pressure are small, and observed associations can vary across different ancestral backgrounds.
Population Frequency and Ancestral Distribution
rs17514846 is a common polymorphic variant observed globally. Across European and East Asian cohorts examined in major genomic databases and genome-wide association studies, the minor allele maintains a frequency typically between 0.35 and 0.45. This high prevalence means that all three possible genotype combinations are widespread throughout general populations, rather than being restricted to rare clinical cases. Because the background frequencies of cardiovascular risk factors and linkage patterns differ among global populations, researchers emphasize that statistical associations found in European cohorts must be interpreted carefully when considering diverse or admixed ancestral groups.
What You Can and Cannot Do With This Information
Understanding your rs17514846 genotype provides educational insight into the genetic architecture of cardiovascular physiology and complex traits, but it cannot be used as a standalone diagnostic tool. Carrying a specific allele does not guarantee longevity, nor does it definitively cause hypertension or heart disease. Complex traits like lifespan and cardiovascular health are shaped by hundreds of genetic loci interacting alongside lifestyle choices, nutrition, exercise, and clinical care. You should never use direct-to-consumer genetic findings to initiate, stop, or change any cardiovascular medication or treatment plan. Any questions regarding blood pressure control, heart health, or pharmacological therapies should always be discussed with a qualified physician or healthcare professional.
How common is this variant?
The minor allele frequency for rs17514846 ranges between approximately 0.35 and 0.45 across both European and East Asian populations. Consequently, heterozygous and homozygous genotypes are commonly observed throughout global cohorts.
Frequently asked questions
Does having the rs17514846 longevity allele mean I will live to 90?
No, carrying a longevity-associated allele at rs17514846 does not guarantee a long life. Complex traits such as lifespan are influenced by hundreds of genetic variants alongside environmental, lifestyle, and medical factors. The statistical link observed in research studies represents a modest population-level trend rather than a personal guarantee.
Can rs17514846 test results diagnose high blood pressure?
No, genetic testing for rs17514846 cannot diagnose hypertension or cardiovascular disease. High blood pressure is diagnosed through routine clinical blood pressure measurements by medical professionals. The variant merely provides insight into subtle regulatory tendencies within cardiovascular biological pathways.
How does the FURIN gene influence cardiovascular health?
The FURIN gene codes for a proprotein convertase enzyme that activates various precursor proteins essential for vascular function and the renin-angiotensin system. Alterations in how much furin enzyme is produced can influence arterial remodeling, lipid levels, and blood pressure control.
Should I change my blood pressure medication based on my genotype?
No, you should never adjust, start, or stop prescribed medications based on genetic results. rs17514846 does not guide clinical drug dosing protocols. Any concerns regarding cardiovascular medications should be evaluated directly with your doctor or pharmacist.
Sources & further reading
Educational information only, last refreshed 9/7/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs17514846?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29